KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Gross Profit (2016 - 2025)

Historic Gross Profit for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $615.8 million.

  • Exact Sciences' Gross Profit rose 2501.72% to $615.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 1793.06%. This contributed to the annual value of $2.3 billion for FY2025, which is 1793.06% up from last year.
  • Per Exact Sciences' latest filing, its Gross Profit stood at $615.8 million for Q4 2025, which was up 2501.72% from $583.9 million recorded in Q3 2025.
  • Exact Sciences' 5-year Gross Profit high stood at $615.8 million for Q4 2025, and its period low was $254.4 million during Q1 2022.
  • Over the past 5 years, Exact Sciences' median Gross Profit value was $441.7 million (recorded in 2023), while the average stood at $417.2 million.
  • In the last 5 years, Exact Sciences' Gross Profit skyrocketed by 7583.69% in 2021 and then tumbled by 2694.91% in 2022.
  • Quarter analysis of 5 years shows Exact Sciences' Gross Profit stood at $354.8 million in 2021, then decreased by 26.95% to $259.2 million in 2022, then skyrocketed by 75.16% to $453.9 million in 2023, then grew by 8.52% to $492.6 million in 2024, then increased by 25.02% to $615.8 million in 2025.
  • Its last three reported values are $615.8 million in Q4 2025, $583.9 million for Q3 2025, and $562.5 million during Q2 2025.